{"title": "Next generation ALS drug silences inherited form of the disease in animal models", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "Next generation ALS drug silences inherited form of the disease in animal models"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/07/180726162043.htm"}], "link": "https://www.sciencedaily.com/releases/2018/07/180726162043.htm", "summary": "Researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results suggest the newer version of the drug may be effective at treating an inherited form of the disease caused by mutations in SOD1.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "Researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results suggest the newer version of the drug may be effective at treating an inherited form of the disease caused by mutations in SOD1."}, "media_thumbnail": [{"url": "https://www.sciencedaily.com/images/2018/07/180726162043-large.jpg", "height": "300", "width": "300"}], "href": "", "published": "Thu, 26 Jul 2018 16:20:43 EDT", "published_parsed": [2018, 7, 26, 20, 20, 43, 3, 207, 0], "id": "https://www.sciencedaily.com/releases/2018/07/180726162043.htm", "guidislink": false}